title: Immortalization with herpesvirus saimiri modulates the cytokine secretion profile of established Th1 and Th2 human T cell clones.
abstract: T blasts of six established human CD4+ T cell clones with defined Ag specificity and cytokine secretion profile (3 Th1 and 3 Th2) were immortalized with Herpesvirus saimiri (HVS) and compared with their uninfected counterparts for their ability to proliferate, produce cytokines, and express cytolytic activity. HVS-transformed Th1 and Th2 clones neither substantially changed their original surface markers nor lose their ability to proliferate in response to their specific Ag but did acquire the ability to proliferate in response to contact signals delivered by SRBC or autologous APC alone. In addition, transformation by HVS substantially enhanced the lectin-dependent cytolytic activity of Th1 clones and enabled noncytolytic Th2 clones to exert cytolytic activity. HVS-transformed Th1 clones but not their uninfected counterparts spontaneously transcribed and secreted Th1-type cytokines (IL-2, IFN-gamma, and TNF-beta) and such a production was further enhanced by stimulation with either SRBC or PMA plus anti-CD3 mAb. HVS transformed but not uninfected Th2 clones constitutively expressed both IL-4 and IL-2 mRNA and secreted IFN-gamma. Stimulation with PMA plus anti-CD3 mAb induced uninfected Th2 clones to secrete high amounts of IL-4 and IL-5 but not Th1-type cytokines, whereas the same HVS-transformed Th2 showed minimal IL-4 and IL-5 secretion with concomitant high production of IL-2, IFN-gamma, and TNF-beta. Transformation by HVS also resulted in up-regulation of TNF-alpha and IL-3 production by both Th1 and Th2 clones. The ongoing proliferation of HVS-transformed clones was partially inhibited by either anti-IL-2 or anti-IL-3 antibodies and virtually abolished by the combined addition of the two anticytokine antibodies, suggesting that both IL-2 and IL-3 can function as autocrine growth factors for HVS-transformed Th1 and Th2 clones.
authors.affiliation: Division of Clinical Immunology and Allergology, University of Florence, Italy.
authors.forename: M
authors.initials: M
authors.lastname: De Carli
authors.forename: S
authors.initials: S
authors.lastname: Berthold
authors.forename: H
authors.initials: H
authors.lastname: Fickenscher
authors.forename: I M
authors.initials: IM
authors.lastname: Fleckenstein
authors.forename: M M
authors.initials: MM
authors.lastname: D'Elios
authors.forename: Q
authors.initials: Q
authors.lastname: Gao
authors.forename: R
authors.initials: R
authors.lastname: Biagiotti
authors.forename: M G
authors.initials: MG
authors.lastname: Giudizi
authors.forename: J R
authors.initials: JR
authors.lastname: Kalden
authors.forename: B
authors.initials: B
authors.lastname: Fleckenstein
mesh_terms: D002472:Cell Transformation, Viral; D002999:Clone Cells; D016207:Cytokines / Q000096:biosynthesis*; D003602:Cytotoxicity, Immunologic; D006567:Herpesvirus 2, Saimiriine / Q000276:immunology*; D006801:Humans; D007377:Interleukin-3 / Q000096:biosynthesis; D008213:Lymphocyte Activation; D010641:Phenotype; D006377:T-Lymphocytes, Helper-Inducer / Q000378:metabolism*; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
chemical_list: D016207:Cytokines; D007377:Interleukin-3; D014409:Tumor Necrosis Factor-alpha